|
Title
|
Published
|
Price
|
|
Trends in Pharmaceutical Deal Making 2009
By: PharmaVentures Ltd.
'Trends in Pharmaceutical Deal Making 2009' is a must-have report for all involved in business development, marketing or competitive intelligence in understanding what lies behind such deals and how they come about.
In
|
more...
|
6/26/2009
|
$2,450.00
|
|
The Royalty Rate Report 2009: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
By: PharmaVentures Ltd.
The Definitive Industry Reference, this report is a “must read” for anyone involved in deal making who wants to get the maximum value from their next deal.
"The report sets out to give the reader
|
more...
|
2/1/2009
|
$5,993.00
|
|
Effective Deal Making in Drug Delivery
By: PharmaVentures Ltd.
"Looming patent expiry a major force in driving valuation"
Drugs with annual sales totalling over US$86 B in 2007 are due to go off patent by 2012. Therefore, the application of novel drug delivery technologies
|
more...
|
2/1/2009
|
$5,993.00
|
|
Guide to Valuation of Pharmaceutical Licensing Deals
By: PharmaVentures Ltd.
Building on an established reputation in the area of deal negotiation and valuation, PharmaVentures is pleased to announce the release of their revised, best-selling Industry Standard Report.
This important Report takes into account all recent
|
more...
|
2/1/2009
|
$2,450.00
|
|
The Royalty Rate Report 2009: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
By: PharmaVentures Ltd.
The Definitive Industry Reference, this report is a “must read” for anyone involved in deal making who wants to get the maximum value from their next deal.
The content has been formulated by leveraging
|
more...
|
11/1/2008
|
$5,993.00
|
|
Competition Law and Intellectual Property Strategy in Pharmaceuticals Sector
By: PharmaVentures Ltd.
Written by the leading-edge experts Bird & Bird the report will provide you with a succinct but comprehensive overview on IP and Competition Law matters.
Leading cases involving GlaxoSmithKline, Boehringer Ingelheim,
|
more...
|
4/17/2008
|
$3,950.00
|
|
A Guide to Royalty Rates in Pharmaceutical Licensing Deals
By: PharmaVentures Ltd.
A Guide to Royalty Rates in Pharmaceutical Licensing Deals provides in-depth information relating to pharmaceutical royalty rates, aiming to bring you the most up-to-date information from our 2007 survey containing royalty rates information from real licensing
|
more...
|
9/24/2007
|
$8,550.00
|
|
Pricing and Reimbursement Risk and Opportunities in Pharmaceutical Deal Making
By: PharmaVentures Ltd.
This report will focus on the critical application of the challenging political and
market environment within the specifi c context of pricing and reimbursement
(P&R) in the process of deal making. The in-licensing of new
|
more...
|
7/1/2007
|
$3,220.00
|
|
The Pharmaceutical Deals of 2006 - Lessons for 2007
By: PharmaVentures Ltd.
In December 2006, GlaxoSmithKline (GSK) and EPIX entered into a worldwide
multi-target strategic collaboration to discover, develop and market novel medicines
targeting four G-protein coupled receptors (GPCRs) for the treatment of a variety
of diseases.
|
more...
|
1/1/2007
|
$499.00
|
|
Effective Licensing & Commercialisation of Drug Delivery Systems 2006
By: PharmaVentures Ltd.
Drug delivery is one of the most important sectors in the pharmaceutical industry and an area in
which effective deal making is essential for survival and growth. Many smaller companies
specialising in drug delivery systems
|
more...
|
10/1/2006
|
$4,250.00
|
|
Deal Making Spotlight on Novartis
By: PharmaVentures Ltd.
Detailing the deal making activities of the top 5 pharmaceutical companies, from 2000 up to and including the whole of 2005, if you are looking to partner with big pharma, these reports are crucial to
|
more...
|
4/1/2006
|
$595.00
|
|
Deal Making Spotlight on Johnson & Johnson
By: PharmaVentures Ltd.
Detailing the deal making activities of the top 5 pharmaceutical companies, from 2000 up to and including the whole of 2005, if you are looking to partner with big pharma, these reports are crucial to
|
more...
|
4/1/2006
|
$595.00
|
|
Deal Making Spotlight on GlaxoSmithKline
By: PharmaVentures Ltd.
Detailing the deal making activities of the top 5 pharmaceutical companies, from 2000 up to and including the whole of 2005, if you are looking to partner with big pharma, these reports are crucial to
|
more...
|
4/1/2006
|
$595.00
|
|
Deal Making Spotlight on sanofi-aventis
By: PharmaVentures Ltd.
Detailing the deal making activities of the top 5 pharmaceutical companies, from 2000 up to and including the whole of 2005, if you are looking to partner with big pharma, these reports are crucial to
|
more...
|
4/1/2006
|
$595.00
|
|
Deal Making Spotlight on Pfizer
By: PharmaVentures Ltd.
Detailing the deal making activities of the top 5 pharmaceutical companies, from 2000 up to and including the whole of 2005, if you are looking to partner with big pharma, these reports are crucial to
|
more...
|
4/1/2006
|
$595.00
|
|
Pharmaceutical Deal Structures - The Essential Manual for Deal Makers
By: PharmaVentures Ltd.
This reference guide provides deal makers with answers to many of the questions that arise in specific deal situations. It is a comprehensive source of information relating to all deal structures and is the ultimate
|
more...
|
3/1/2006
|
$1,650.00
|
|
Spotlight on Influenza - Separating Fact from Fiction in the Battle of Influenza
By: PharmaVentures Ltd.
Focusing on the hot topic of influenza, this report offers a topical insight into both the flu virus and the methods being employed to tackle it. From an investigative angle, the report specifically explores the
|
more...
|
2/1/2006
|
$845.00
|
|
Strategies and Tactics For Successful Partnering
By: PharmaVentures Ltd.
Strategies and Tactics for Successful Partnering is a practical
guide to the successful partnering of biotechnology and
pharmaceutical projects. It provides you with in-depth insights into
all the different stages of the partnering process and
|
more...
|
10/1/2005
|
$1,650.00
|
|
Valuing and Structuring Pharmaceutical Licensing Agreements
By: PharmaVentures Ltd.
This publication provides an essential grounding in how to use accepted and reliable methods for valuing pharmaceutical and biotech projects. Whether you are about to negotiate a licensing deal or need to perform a rigorous
|
more...
|
2/1/2003
|
$3,750.00
|
|
Title
|
Published
|
Price
|
(0 items)
